Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
59 Cards in this Set
- Front
- Back
Hemostasis consits of a series of reactions which act to do what?
|
Stop bleeding
|
|
What are the 3 phases that occur in rapid sequence in hemostasis?
|
Vascular spasms, platelet plug formation, and coagulation.
|
|
What is the immediate vasoconstriction in response to injury called?
|
Vascular spasms
|
|
Blood cotting and fibrin clot formation are examples of what?
|
Coagulation
|
|
List what occurs in response to tissue injury.
|
Vascular spasm
Platelet plug formation Blood clot formation – coagulation Clot retraction Fibrinolysis Reorganization Repair and regeneration |
|
Vascular spasm can also be called...
|
vasospasm or vasoconstriction
|
|
T/F
Vascular spasm is spontaneous. |
True!
|
|
Vascular spasm is (immediate/delayed) and (temporary/long-lasting).
|
Immediate, temporary
It lasts for a maximum of 30 minutes. |
|
Vascular spasm can be triggered by what 3 things?
|
Direct injury to vascular smooth muscle
Chemicals released by endothelial cells and platelets Initiated/maintained/ by local pain receptors |
|
Spasm mechanism becomes (less/more) efficient as the amount of tissue damage increases.
|
More
|
|
Spasm is most effective in (small/large) vessels.
|
Small
|
|
What does blood need to be exposed to in order to initiate platelet plug formation?
|
Damaged endothelium, underyling collagen
|
|
What are the 5 steps in platelet plug formation?
|
1. Activation
2. Adhesion 3. Aggregation 4. Cohesion 5. Temporary and permanent plug |
|
What is the KEY step in blood clotting?
|
The conversion of fibrinogen to fibrin by thrombin.
|
|
What are the 3 basic steps of blood coagulation?
|
1. Formation of PROTHROMBIN ACTIVATOR
2. Formation of THROMBIN 3. Conversion of Fibrinogen to Fibrin |
|
Rupture of a vessel and damage of endothelium will cause what to begin?
|
Activation of prothrombin activator (PA).
|
|
Prothrombin activator (PA) can be formed by (extrinsic/intrinsic) pathways.
|
Trick question!
It can be formed by either extrinsic or intrinsic pathways |
|
What is PA's main function?
|
Activates prothrombin (go figure)
|
|
PA catalyzes what reaction?
|
Conversion of prothrombin to thrombin
|
|
What factors form prothrombin activator?
|
activated factor X
factor V Phospholipids Ca2+ |
|
What is the intrinsic (vascular) pathway for the formation of PA initiated by?
|
Surface contact (contact activation): coming in contact with an activated platelet.
|
|
What is the extrinsic (extravascular) pathway for the formation of PA initiated by?
|
Tissue factor activation: initiated by tissues outside the vascular system.
Each pathway cascades toward factor X |
|
Which formation of PA pathway is triggered by the exposure of collagens in the vascular wall to factor XII and thrombocytes?
|
Intrinsic pathway
|
|
Which formation of PA pathway is slow to proceed and can take 2-6 minutes?
|
Intrinsic pathway
|
|
Which formation of PA pathway has many inhibitory or antagonistic mechanisms that exist in the blood?
|
Intrinsic pathway
|
|
Which formation of PA pathway is triggered by tissue trauma?
|
Extrinsic pathway
|
|
Which formation of PA pathway is explosive in nature and can be completed in 15 seconds?
|
Extrinsic pathway
|
|
Which formation of PA pathway has no inhibitory mechanisms counteracting it?
|
Extrinsic pathway
|
|
What acts as the catalyst to convert the plasma protein fibrinogen to soluble fibrin?
|
Thrombin
|
|
How do fibrin threads lead to coagulation?
|
These fibrin threads form a meshwork, so blood cells get entangled in it to form the clot or coagulum.
|
|
What is needed to activate factor XIII?
|
Thrombin and Ca2+
|
|
What do factor XIII(activated) and Ca2+ do together?
|
Convert fibrin monomer (soluble) to polymer (insoluble).
|
|
Why is factor XIII a fibrin stabilizing factor?
|
Cross-links fibrin
Strengthens and stabilizes the clot (polymer, insoluble) |
|
How do clots retract?
|
Actin and myosin in the fibrin mesh platelets retract ("contract") and serum is extruded from the fibrin mesh. This causes the clot to retract.
|
|
During repair of the vascular wall, what stimulates rebuilding of the blood vessel wall?
|
Platelet-derived growth factor (PDGF)
|
|
In repair of the vascular wall, what do fibroblasts form?
|
A connective tissue patch
|
|
In repair of the vascular wall, endothelial cells multiply and restore the endothelial lining. What stimulates this?
|
Vascular endothelial growth factor (VEGF)
|
|
Name the inactive precursor of the proteolytic enzyme plasmin. It is present in normal blood.
|
Plasminogen
|
|
What activates the conversion of plasminogen to plasmin (or fibrinolysin)?
Where are they found? |
Tissue plasminogen activators (tPA).
In tissues, plasma, and urine |
|
T/F
There are physiological mechanisms that cause the clots to form at the site where a blood vessel is injured but keep the vessel lumen free of clots. |
True!
|
|
Interaction between the platelet-aggregating factors (thromboxane A2) and anti-aggregating factor (prostacyclin) are part of what mechanisms?
|
Anticlotting mechanisms
|
|
Name the circulating protease inhibitor that binds to serine proteases in the coagulation system, blocking their activity as clotting factors.
What is this reaction facilitated by? |
Antithrombin III
Heparin |
|
Name the thrombin-binding protein that endothelial cells produce.
When thrombin binds this protein, it becomes what? |
Thrombomodulin
Anticoagulant |
|
What complex activates the fibrinolytic system (plasminogen-plasmin system)?
|
Thrombomodulin-thrombin complex
|
|
Intact, smooth, functional endothelium is an example of an (in vivo/in vitro) anticoagulant.
|
In vivo
|
|
Heparin is an example of an (in vitro/in vivo) anticoagulant.
|
Both!
|
|
[Thrombin + thrombomodulin] is an example of an (in vitro/in vivo) anticoagulant.
|
In vivo
|
|
Prostacyclin is an example of an (in vitro/in vivo) anticoagulant.
|
In vivo
|
|
[Thromboxane A2+prostacyclin] is an example of an (in vitro/in vivo) anticoagulant.
|
In vivo
|
|
Antithrombin III is an example of an (in vitro/in vivo) anticoagulant.
|
In vivo
|
|
Thrombomodulin is an example of an (in vitro/in vivo) anticoagulant.
|
In vivo
|
|
The plasminogen system (fibrinolysins) is an example of an (in vitro/in vivo) anticoagulant.
|
In vivo
|
|
Vitamin K antagonists (inhibit activity of VII, IX, and X), such as Dicumarol, Warfavin, and Diphenadlone, are examples of (in vitro/in vivo) anticoagulants.
|
In vitro
|
|
Calcium chelators, such as sodium citrate and ethylene diamine tetraacetic acid (EDTA), are examples of (in vitro/in vivo) anticoagulants.
|
In vitro
|
|
What are three types of clotting abnormalities?
|
Hemorrhagic diseases (bleeding disorders)
Thrombosis: Thrombi and emboli Disseminated intravascular coagulation (thrombi and bleeding) |
|
Which clotting abnormality is due to deficiencies of the clotting factors (Hemophilia A- factor VIII deficiency)?
|
Hemorrhagic diseases (bleeding disorders)
|
|
Which clotting abnormality is due to uncontrolled intravascular coagulation?
|
Thrombosis: Thrombi and emboli
|
|
Which clotting abnormality is due to the consumption of platelets and increased coagulation factors and excessive thrombi formation in many small- and medium-sized vessels (and bleeding at the same time)?
|
Disseminated intravascular coagulation (thrombi and bleeding)
|
|
What are 2 platelets disorders (bleeding disorders)?
|
Thrombocytopenia (low number of platelets)
Thrombasthenia (low function of platelets) |